Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma

  • Authors:
    • Shinichi Umeda
    • Mitsuro Kanda
    • Masahiko Koike
    • Haruyoshi Tanaka
    • Takashi Miwa
    • Chie Tanaka
    • Daisuke Kobayashi
    • Masaya Suenaga
    • Masamichi Hayashi
    • Suguru Yamada
    • Goro Nakayama
    • Yasuhiro Kodera
  • View Affiliations

  • Published online on: September 27, 2018     https://doi.org/10.3892/or.2018.6742
  • Pages: 3772-3780
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Patients with esophageal squamous cell carcinoma (ESCC) have a poor prognosis. Identification of biomarkers to accurately predict the risk of recurrence and survival following curative esophageal resection is required to improve patient outcomes. The copine 5 (CPNE5) gene encodes a calcium‑dependent lipid‑binding intracellular protein. Copine proteins interact with diverse target proteins that are components of pathways that aberrantly regulate the phenotypes of malignant cells. However, limited information is available on the role of CPNE5 in cancer. The present study investigated whether CPNE5 may serve as a predictive marker of the prognosis of patients with ESCC following curative resection. CPNE5 mRNA expression levels and the methylation status of the CPNE5 promotor region were measured in 11 ESCC cell lines. CPNE5 mRNA expression levels in 106 pairs of surgically resected specimens were measured, and their associations with clinicopathological characteristics were analyzed. The CPNE5 mRNA expression levels in 9 ESCC cell lines were decreased compared with those of the non-tumorigenic esophageal mucosa cell line Het‑1A. Bisulfite sequencing detected the methylation of the CPNE5 promotor region in all cell lines tested, including Het‑1A. Furthermore, analysis of tissues revealed that CPNE5 mRNA expression was significantly lower in ESCC cells compared with cognate non-cancerous adjacent mucosal cells. Kaplan‑Meier analysis revealed that patients with low CPNE5 expression experienced significantly shorter overall survival. Multivariable analysis identified low CPNE5 expression to be an independent prognostic factor of OS. Analysis of recurrence patterns revealed that significantly more patients with local recurrence expressed lower levels of CPNE5 mRNA. These findings indicated that CPNE5 expression in ESCC tissues may serve as an informative biomarker for predicting ESCC recurrence, particularly in patients with local recurrence, and may help to ensure that patients receive optimal treatment and follow‑up.

References

1 

Lagergren J, Smyth E, Cunningham D and Lagergren P: Oesophageal cancer. Lancet. 390:2383–2396. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, et al: Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391:1023–1075. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Tanaka H, Kanda M, Koike M, Iwata N, Shimizu D, Ezaka K, Sueoka S, Tanaka Y, Takami H, Hashimoto R, et al: Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus. Int J Oncol. 47:1811–1818. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Xi M, Yang Y, Zhang L, Yang H, Merrell KW, Hallemeier CL, Shen RK, Haddock MG, Hofstetter WL, Maru DM, et al: Multi-institutional analysis of recurrence and survival after neoadjuvant chemoradiotherapy of esophageal cancer: Impact of histology on recurrence patterns and outcomes. Ann Surg. 2018. View Article : Google Scholar

5 

Chen HS, Hsu PK, Liu CC and Wu SC: Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma. Sci Rep. 8:21802018. View Article : Google Scholar : PubMed/NCBI

6 

Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, et al: Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Oncol Rep. 31:693–700. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Kunzmann AT, McMenamin ÚC, Spence AD, Gray RT, Murray LJ, Turkington RC and Coleman HG: Blood biomarkers for early diagnosis of oesophageal cancer: A systematic review. Eur J Gastroenterol Hepatol. 30:263–273. 2018.PubMed/NCBI

8 

Tripodis N, Mason R, Humphray SJ, Davies AF, Herberg JA, Trowsdale J, Nizetic D, Senger G and Ragoussis J: Physical map of human 6p21.2-6p21.3: Region flanking the centromeric end of the major histocompatibility complex. Genome Res. 8:631–643. 1998. View Article : Google Scholar : PubMed/NCBI

9 

Creutz CE, Tomsig JL, Snyder SL, Gautier MC, Skouri F, Beisson J and Cohen J: The copines, a novel class of C2 domain-containing, calcium-dependent, phospholipid-binding proteins conserved from Paramecium to humans. J Biol Chem. 273:1393–1402. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, et al: Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 13:397–406. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Ding X, Jin Y, Wu Y, Wu Y, Wu H, Xiong L, Song X, Liu S, Fan W and Fan M: Localization and cellular distribution of CPNE5 in embryonic mouse brain. Brain Res. 1224:20–28. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Wang KS, Zuo L, Pan Y, Xie C and Luo X: Genetic variants in the CPNE5 gene are associated with alcohol dependence and obesity in Caucasian populations. J Psychiatr Res. 71:1–7. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Kidger AM, Sipthorp J and Cook SJ: ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. Pharmacol Ther. 187:45–60. 2018. View Article : Google Scholar : PubMed/NCBI

14 

Hsieh FS, Hung MH, Wang CY, Chen YL, Hsiao YJ, Tsai MH, Li JR, Chen LJ, Shih CT, Chao TI, et al: Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation. Lung Cancer. 112:81–89. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Schlessinger K, McManus EJ and Hall A: Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J Cell Biol. 178:355–361. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Tomsig JL, Snyder SL and Creutz CE: Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif. J Biol Chem. 278:10048–10054. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Tsunoo H, Komura S, Ohishi N, Yajima H, Akiyama S, Kasai Y, Ito K, Nakao A and Yagi K: Effect of transfection with human interferon-beta gene entrapped in cationic multilamellar liposomes in combination with 5-fluorouracil on the growth of human esophageal cancer cells in vitro. Anticancer Res. 22:1537–1543. 2002.PubMed/NCBI

18 

Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer. 69:277–284. 1992. View Article : Google Scholar : PubMed/NCBI

19 

Miwa T, Kanda M, Koike M, Iwata N, Tanaka H, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, et al: Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus. Oncol Lett. 14:4822–4828. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Sobin LH, Gospodarowicz MK and Wittekind Ch: International Union Against CancerTNM Classification of Malignant Tumours. 7th edition. Wiley-Blackwell; New York, NY: pp. 66–72. 2009

21 

Kanda M, Shimizu D, Sueoka S, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, et al: Prognostic relevance of SAMSN1 expression in gastric cancer. Oncol Lett. 12:4708–4716. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Shimizu D, Kanda M, Tanaka H, Kobayashi D, Tanaka C, Hayashi M, Iwata N, Niwa Y, Takami H, Yamada S, et al: GPR155 serves as a predictive biomarker for hematogenous metastasis in patients with gastric cancer. Sci Rep. 7:420892017. View Article : Google Scholar : PubMed/NCBI

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Kanda M, Tanaka C, Kobayashi D, Tanaka H, Shimizu D, Shibata M, Takami H, Hayashi M, Iwata N, Niwa Y, et al: Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer. Int J Cancer. 139:2290–2298. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Beck S, Rhee C, Song J, Lee BK, LeBlanc L, Cannon L and Kim J: Implications of CpG islands on chromosomal architectures and modes of global gene regulation. Nucleic Acids Res. 46:4362–4391. 2018. View Article : Google Scholar

26 

Pu W, Wang C, Chen S, Zhao D, Zhou Y, Ma Y, Wang Y, Li C, Huang Z, Jin L, et al: Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Clin Epigenetics. 9:1292017. View Article : Google Scholar : PubMed/NCBI

27 

Kailasam A, Mittal SK and Agrawal DK: Epigenetics in the pathogenesis of esophageal adenocarcinoma. Clin Transl Sci. 8:394–402. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Dong G, Mao Q, Yu D, Zhang Y, Qiu M, Dong G, Chen Q, Xia W, Wang J, Xu L, et al: Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy. Sci Rep. 7:420602017. View Article : Google Scholar : PubMed/NCBI

29 

Chen XX, Zhong Q, Liu Y, Yan SM, Chen ZH, Jin SZ, Xia TL, Li RY, Zhou AJ, Su Z, et al: Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. Nat Commun. 8:5242017. View Article : Google Scholar : PubMed/NCBI

30 

Zhang D, Zheng Y, Wang Z, Huang Q, Cao X, Wang F and Liu S: Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery. Eur J Surg Oncol. 43:1949–1955. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Zhang SS, Yang H, Xie X, Luo KJ, Wen J, Bella AE, Hu Y, Yang F and Fu JH: Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: A meta-analysis of randomized controlled trials and nonrandomized studies. Dis Esophagus. 27:574–584. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Wu SG, Zhang WW, He ZY, Sun JY, Chen YX and Guo L: Sites of metastasis and overall survival in esophageal cancer: A population-based study. Cancer Manag Res. 9:781–788. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Guo JC, Lin CC, Huang TC, Huang PM, Kuo HY, Chang CH, Wang CC, Cheng JC, Yeh KH, Hsu CH, et al: Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Anticancer Res. 38:1569–1577. 2018.PubMed/NCBI

34 

Tam PC, Siu KF, Cheung HC, Ma L and Wong J: Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg. 205:189–194. 1987. View Article : Google Scholar : PubMed/NCBI

35 

Catalano MF, Sivak MV Jr, Rice TW and Van Dam J: Postoperative screening for anastomotic recurrence of esophageal carcinoma by endoscopic ultrasonography. Gastrointest Endosc. 42:540–544. 1995. View Article : Google Scholar : PubMed/NCBI

36 

Kim TJ, Lee KH, Kim YH, Sung SW, Jheon S, Cho SK and Lee KW: Postoperative imaging of esophageal cancer: What chest radiologists need to know. Radiographics. 27:409–429. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

December 2018
Volume 40 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Umeda, S., Kanda, M., Koike, M., Tanaka, H., Miwa, T., Tanaka, C. ... Kodera, Y. (2018). Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma. Oncology Reports, 40, 3772-3780. https://doi.org/10.3892/or.2018.6742
MLA
Umeda, S., Kanda, M., Koike, M., Tanaka, H., Miwa, T., Tanaka, C., Kobayashi, D., Suenaga, M., Hayashi, M., Yamada, S., Nakayama, G., Kodera, Y."Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma". Oncology Reports 40.6 (2018): 3772-3780.
Chicago
Umeda, S., Kanda, M., Koike, M., Tanaka, H., Miwa, T., Tanaka, C., Kobayashi, D., Suenaga, M., Hayashi, M., Yamada, S., Nakayama, G., Kodera, Y."Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma". Oncology Reports 40, no. 6 (2018): 3772-3780. https://doi.org/10.3892/or.2018.6742